Igor Koturbash
Concepts (387)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epigenesis, Genetic | 28 | 2022 | 374 | 6.090 |
Why?
| DNA Methylation | 39 | 2020 | 548 | 6.020 |
Why?
| Plant Extracts | 8 | 2024 | 190 | 4.640 |
Why?
| Cannabidiol | 7 | 2024 | 37 | 4.430 |
Why?
| Radiation, Ionizing | 15 | 2019 | 100 | 3.900 |
Why?
| Dietary Supplements | 9 | 2024 | 443 | 3.880 |
Why?
| Methionine | 10 | 2024 | 135 | 3.530 |
Why?
| DNA Damage | 25 | 2021 | 301 | 3.200 |
Why?
| Cannabis | 6 | 2024 | 145 | 2.810 |
Why?
| Mice, Inbred C57BL | 34 | 2024 | 1816 | 2.560 |
Why?
| Animals | 80 | 2024 | 13187 | 2.460 |
Why?
| MicroRNAs | 12 | 2017 | 353 | 2.220 |
Why?
| Mice | 51 | 2024 | 5739 | 2.090 |
Why?
| Spleen | 11 | 2016 | 172 | 2.020 |
Why?
| Liver | 15 | 2024 | 1115 | 2.010 |
Why?
| Radiation Injuries | 6 | 2024 | 113 | 1.840 |
Why?
| Long Interspersed Nucleotide Elements | 5 | 2017 | 38 | 1.800 |
Why?
| Chromosome Aberrations | 6 | 2022 | 297 | 1.730 |
Why?
| Neoplasms | 11 | 2024 | 1235 | 1.720 |
Why?
| Space Flight | 4 | 2021 | 34 | 1.560 |
Why?
| Heart | 6 | 2023 | 326 | 1.420 |
Why?
| Bystander Effect | 6 | 2009 | 26 | 1.360 |
Why?
| Genomic Instability | 6 | 2010 | 92 | 1.290 |
Why?
| Radiation Injuries, Experimental | 3 | 2020 | 81 | 1.290 |
Why?
| Plant Preparations | 2 | 2024 | 38 | 1.170 |
Why?
| Histones | 14 | 2018 | 312 | 1.160 |
Why?
| Herb-Drug Interactions | 2 | 2024 | 31 | 1.150 |
Why?
| Male | 52 | 2024 | 25241 | 1.140 |
Why?
| Particulate Matter | 3 | 2016 | 52 | 1.110 |
Why?
| Dose-Response Relationship, Radiation | 14 | 2023 | 184 | 1.090 |
Why?
| Iron | 4 | 2015 | 122 | 1.080 |
Why?
| Melanoma | 2 | 2020 | 285 | 1.060 |
Why?
| Hematopoietic Stem Cells | 3 | 2017 | 184 | 1.050 |
Why?
| Methionine Adenosyltransferase | 2 | 2018 | 19 | 1.050 |
Why?
| Repetitive Sequences, Nucleic Acid | 6 | 2019 | 96 | 1.040 |
Why?
| Apoptosis | 11 | 2019 | 1101 | 1.030 |
Why?
| DNA | 8 | 2024 | 541 | 1.030 |
Why?
| Gastrointestinal Tract | 3 | 2022 | 103 | 1.030 |
Why?
| Lung | 5 | 2016 | 486 | 0.980 |
Why?
| 5-Methylcytosine | 2 | 2022 | 16 | 0.980 |
Why?
| Intestine, Small | 2 | 2020 | 109 | 0.980 |
Why?
| Tumor Suppressor Protein p53 | 5 | 2016 | 202 | 0.970 |
Why?
| gamma-Aminobutyric Acid | 1 | 2024 | 65 | 0.930 |
Why?
| Disease Models, Animal | 5 | 2020 | 1455 | 0.910 |
Why?
| Macrophages | 5 | 2021 | 363 | 0.900 |
Why?
| Drug Approval | 2 | 2020 | 47 | 0.900 |
Why?
| Dose-Response Relationship, Drug | 10 | 2020 | 1376 | 0.830 |
Why?
| Astronauts | 2 | 2024 | 5 | 0.820 |
Why?
| Lymphocytes | 2 | 2022 | 152 | 0.820 |
Why?
| Rodentia | 1 | 2022 | 18 | 0.800 |
Why?
| Tandem Mass Spectrometry | 2 | 2022 | 236 | 0.800 |
Why?
| Humans | 47 | 2024 | 49974 | 0.790 |
Why?
| Environmental Pollution | 1 | 2021 | 11 | 0.760 |
Why?
| Environmental Exposure | 5 | 2017 | 199 | 0.750 |
Why?
| Butadienes | 2 | 2011 | 48 | 0.740 |
Why?
| Carbon | 2 | 2019 | 54 | 0.740 |
Why?
| Cytochrome P-450 Enzyme System | 3 | 2020 | 195 | 0.730 |
Why?
| Cell Transformation, Neoplastic | 3 | 2018 | 177 | 0.730 |
Why?
| Hepatocytes | 3 | 2019 | 182 | 0.720 |
Why?
| Abdomen | 1 | 2020 | 76 | 0.710 |
Why?
| Myocardium | 3 | 2019 | 436 | 0.710 |
Why?
| Acute Radiation Syndrome | 1 | 2020 | 12 | 0.710 |
Why?
| Colitis | 1 | 2020 | 50 | 0.690 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 2019 | 10 | 0.680 |
Why?
| Gene Expression | 7 | 2019 | 609 | 0.670 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 19 | 0.660 |
Why?
| DNA Transposable Elements | 3 | 2015 | 107 | 0.660 |
Why?
| Tea | 1 | 2019 | 30 | 0.650 |
Why?
| Protons | 5 | 2023 | 69 | 0.650 |
Why?
| Cannabinoids | 1 | 2020 | 105 | 0.650 |
Why?
| Carcinogens, Environmental | 3 | 2015 | 22 | 0.640 |
Why?
| Sex Characteristics | 3 | 2010 | 190 | 0.640 |
Why?
| Heavy Ions | 3 | 2015 | 15 | 0.640 |
Why?
| Cells | 1 | 2018 | 3 | 0.630 |
Why?
| Carcinogens | 5 | 2012 | 199 | 0.600 |
Why?
| Oxygen | 2 | 2023 | 326 | 0.590 |
Why?
| Clofibrate | 1 | 2017 | 7 | 0.590 |
Why?
| Phenobarbital | 1 | 2017 | 17 | 0.590 |
Why?
| Bacteria | 1 | 2019 | 224 | 0.580 |
Why?
| Oxidative Stress | 5 | 2017 | 770 | 0.570 |
Why?
| Methylation | 5 | 2022 | 122 | 0.560 |
Why?
| Acetaminophen | 1 | 2019 | 283 | 0.540 |
Why?
| Epigenomics | 5 | 2017 | 67 | 0.540 |
Why?
| Pharmacogenetics | 1 | 2015 | 52 | 0.510 |
Why?
| Safety | 1 | 2015 | 78 | 0.510 |
Why?
| DNA, Neoplasm | 1 | 2015 | 147 | 0.500 |
Why?
| Liver Neoplasms, Experimental | 2 | 2013 | 50 | 0.500 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 828 | 0.500 |
Why?
| Environmental Pollutants | 1 | 2015 | 91 | 0.470 |
Why?
| Obesity | 3 | 2019 | 1113 | 0.460 |
Why?
| Toxicity Tests | 3 | 2020 | 52 | 0.450 |
Why?
| Whole-Body Irradiation | 6 | 2020 | 131 | 0.450 |
Why?
| Lysine | 3 | 2013 | 89 | 0.430 |
Why?
| Cell Proliferation | 8 | 2011 | 1007 | 0.420 |
Why?
| DNA Adducts | 3 | 2012 | 78 | 0.420 |
Why?
| Vitamins | 2 | 2022 | 64 | 0.420 |
Why?
| Female | 25 | 2024 | 26472 | 0.420 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2012 | 24 | 0.410 |
Why?
| Xenobiotics | 1 | 2012 | 30 | 0.400 |
Why?
| Cosmic Radiation | 4 | 2023 | 31 | 0.400 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 57 | 0.400 |
Why?
| Mice, Inbred CBA | 4 | 2021 | 35 | 0.390 |
Why?
| Cranial Irradiation | 2 | 2008 | 21 | 0.380 |
Why?
| Species Specificity | 2 | 2024 | 192 | 0.380 |
Why?
| Paternal Exposure | 2 | 2009 | 4 | 0.370 |
Why?
| Neoplasm Metastasis | 3 | 2018 | 231 | 0.360 |
Why?
| Frontal Lobe | 1 | 2010 | 48 | 0.360 |
Why?
| Antineoplastic Agents | 1 | 2018 | 1171 | 0.360 |
Why?
| DNA Repair | 6 | 2021 | 193 | 0.360 |
Why?
| United States Food and Drug Administration | 2 | 2020 | 93 | 0.350 |
Why?
| Maternal Exposure | 2 | 2009 | 86 | 0.350 |
Why?
| Gene Expression Profiling | 4 | 2019 | 1032 | 0.350 |
Why?
| Inflammation | 1 | 2014 | 604 | 0.340 |
Why?
| Nanoparticles | 3 | 2015 | 145 | 0.340 |
Why?
| Rats | 11 | 2023 | 3305 | 0.340 |
Why?
| Escherichia coli O157 | 1 | 2009 | 12 | 0.340 |
Why?
| Mice, Inbred Strains | 3 | 2019 | 161 | 0.340 |
Why?
| Cerebellum | 1 | 2010 | 135 | 0.330 |
Why?
| Neoplasms, Radiation-Induced | 3 | 2016 | 38 | 0.330 |
Why?
| Reactive Oxygen Species | 3 | 2015 | 408 | 0.320 |
Why?
| Transcriptome | 3 | 2020 | 315 | 0.320 |
Why?
| RNA-Induced Silencing Complex | 1 | 2008 | 2 | 0.320 |
Why?
| Hippocampus | 1 | 2010 | 228 | 0.310 |
Why?
| Escherichia coli | 1 | 2009 | 186 | 0.310 |
Why?
| Chemokines | 2 | 2020 | 77 | 0.300 |
Why?
| DNA, Satellite | 2 | 2019 | 11 | 0.300 |
Why?
| Thymus Gland | 5 | 2008 | 42 | 0.300 |
Why?
| Radiation Dosage | 5 | 2020 | 157 | 0.290 |
Why?
| Energy Metabolism | 2 | 2020 | 282 | 0.280 |
Why?
| Arkansas | 2 | 2022 | 1977 | 0.280 |
Why?
| Radiation | 1 | 2005 | 15 | 0.260 |
Why?
| Nootropic Agents | 1 | 2024 | 5 | 0.250 |
Why?
| Bilirubin | 1 | 2024 | 40 | 0.240 |
Why?
| Risk Assessment | 4 | 2019 | 1259 | 0.240 |
Why?
| Writing | 1 | 2024 | 43 | 0.240 |
Why?
| Body Weight | 2 | 2020 | 513 | 0.240 |
Why?
| Mammary Glands, Animal | 4 | 2015 | 69 | 0.240 |
Why?
| Diet | 4 | 2024 | 566 | 0.230 |
Why?
| Time Factors | 5 | 2015 | 2903 | 0.230 |
Why?
| Chromatography, Liquid | 2 | 2022 | 232 | 0.230 |
Why?
| Ions | 2 | 2023 | 33 | 0.220 |
Why?
| Substance Withdrawal Syndrome | 1 | 2024 | 169 | 0.220 |
Why?
| Bone Marrow Cells | 2 | 2021 | 191 | 0.210 |
Why?
| Blotting, Western | 4 | 2011 | 601 | 0.210 |
Why?
| Cytogenetic Analysis | 1 | 2022 | 82 | 0.210 |
Why?
| Precancerous Conditions | 3 | 2013 | 83 | 0.210 |
Why?
| Linear Energy Transfer | 3 | 2017 | 14 | 0.200 |
Why?
| Permeability | 1 | 2022 | 68 | 0.200 |
Why?
| 2-Acetylaminofluorene | 2 | 2011 | 30 | 0.200 |
Why?
| Metabolic Networks and Pathways | 2 | 2019 | 89 | 0.200 |
Why?
| Biomedical Research | 1 | 2024 | 237 | 0.190 |
Why?
| Gene Expression Regulation | 3 | 2017 | 976 | 0.190 |
Why?
| Drug Resistance, Neoplasm | 2 | 2015 | 308 | 0.190 |
Why?
| Taurine | 1 | 2020 | 15 | 0.190 |
Why?
| Intestines | 1 | 2022 | 176 | 0.180 |
Why?
| Mucin-2 | 1 | 2020 | 7 | 0.180 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 94 | 0.180 |
Why?
| Cell Line | 5 | 2015 | 1000 | 0.180 |
Why?
| Gamma Rays | 2 | 2017 | 49 | 0.180 |
Why?
| Administration, Oral | 2 | 2018 | 426 | 0.180 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 595 | 0.170 |
Why?
| X-Rays | 5 | 2010 | 55 | 0.170 |
Why?
| Colon | 1 | 2020 | 98 | 0.170 |
Why?
| Malnutrition | 1 | 2021 | 87 | 0.170 |
Why?
| Centromere | 1 | 2019 | 11 | 0.170 |
Why?
| Glutamine | 1 | 2020 | 171 | 0.170 |
Why?
| Cytokines | 2 | 2020 | 612 | 0.170 |
Why?
| Liver Function Tests | 1 | 2019 | 47 | 0.170 |
Why?
| Germ Cells | 2 | 2009 | 12 | 0.170 |
Why?
| Tight Junctions | 1 | 2019 | 24 | 0.160 |
Why?
| Oxygen Radioisotopes | 1 | 2019 | 14 | 0.160 |
Why?
| Drug Synergism | 1 | 2019 | 150 | 0.160 |
Why?
| Thinness | 1 | 2019 | 46 | 0.160 |
Why?
| Down-Regulation | 2 | 2011 | 348 | 0.160 |
Why?
| Intestinal Mucosa | 1 | 2020 | 225 | 0.160 |
Why?
| Copper | 2 | 2015 | 43 | 0.160 |
Why?
| Models, Genetic | 2 | 2017 | 170 | 0.160 |
Why?
| Substance-Related Disorders | 1 | 2024 | 600 | 0.160 |
Why?
| Aging | 2 | 2014 | 687 | 0.150 |
Why?
| Animals, Outbred Strains | 1 | 2017 | 11 | 0.150 |
Why?
| Acetylation | 3 | 2013 | 97 | 0.150 |
Why?
| Pandemics | 1 | 2022 | 559 | 0.150 |
Why?
| Retroelements | 1 | 2017 | 14 | 0.150 |
Why?
| Gene-Environment Interaction | 1 | 2017 | 36 | 0.150 |
Why?
| Metagenome | 1 | 2017 | 41 | 0.150 |
Why?
| Weightlessness Simulation | 1 | 2017 | 19 | 0.150 |
Why?
| Brain | 3 | 2019 | 1328 | 0.150 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 349 | 0.150 |
Why?
| Hematopoiesis | 1 | 2017 | 71 | 0.150 |
Why?
| Spectral Karyotyping | 1 | 2017 | 6 | 0.140 |
Why?
| RNA, Messenger | 1 | 2020 | 1105 | 0.140 |
Why?
| Metabolomics | 1 | 2018 | 126 | 0.140 |
Why?
| Drug Evaluation, Preclinical | 1 | 2017 | 144 | 0.140 |
Why?
| Survival Analysis | 1 | 2019 | 653 | 0.140 |
Why?
| Organ Size | 1 | 2017 | 226 | 0.140 |
Why?
| Molecular Targeted Therapy | 1 | 2018 | 119 | 0.140 |
Why?
| Rats, Inbred F344 | 1 | 2017 | 196 | 0.140 |
Why?
| Mutation | 4 | 2018 | 1294 | 0.140 |
Why?
| Feeding Behavior | 1 | 2018 | 181 | 0.140 |
Why?
| Radioactive Hazard Release | 1 | 2016 | 14 | 0.140 |
Why?
| Metabolome | 1 | 2017 | 89 | 0.140 |
Why?
| Cells, Cultured | 3 | 2016 | 1573 | 0.140 |
Why?
| Azacitidine | 1 | 2016 | 34 | 0.140 |
Why?
| Cell Line, Tumor | 2 | 2018 | 1403 | 0.140 |
Why?
| Cell Culture Techniques | 1 | 2016 | 99 | 0.140 |
Why?
| Blood Glucose | 1 | 2019 | 439 | 0.130 |
Why?
| DNA-Binding Proteins | 2 | 2009 | 427 | 0.130 |
Why?
| Tocotrienols | 1 | 2016 | 37 | 0.130 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2017 | 259 | 0.130 |
Why?
| Interleukin-13 | 1 | 2015 | 15 | 0.130 |
Why?
| Radiotherapy | 1 | 2016 | 128 | 0.130 |
Why?
| Cytotoxins | 1 | 2015 | 16 | 0.130 |
Why?
| Vitamin E | 1 | 2016 | 81 | 0.130 |
Why?
| Echocardiography | 1 | 2018 | 378 | 0.130 |
Why?
| Macrophages, Alveolar | 1 | 2015 | 28 | 0.130 |
Why?
| Hazardous Substances | 1 | 2015 | 15 | 0.130 |
Why?
| Radiography | 1 | 2016 | 489 | 0.130 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 237 | 0.130 |
Why?
| Genetic Markers | 2 | 2015 | 102 | 0.130 |
Why?
| Methyltransferases | 2 | 2015 | 27 | 0.130 |
Why?
| Benzhydryl Compounds | 1 | 2015 | 67 | 0.120 |
Why?
| Uterus | 1 | 2015 | 94 | 0.120 |
Why?
| Prostate | 1 | 2015 | 117 | 0.120 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 267 | 0.120 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 181 | 0.120 |
Why?
| Gene Dosage | 1 | 2014 | 78 | 0.120 |
Why?
| Rats, Sprague-Dawley | 3 | 2015 | 1597 | 0.120 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 18 | 0.120 |
Why?
| Risk Factors | 2 | 2020 | 3613 | 0.120 |
Why?
| L-Lactate Dehydrogenase | 1 | 2014 | 65 | 0.120 |
Why?
| In Situ Nick-End Labeling | 1 | 2014 | 57 | 0.120 |
Why?
| Random Allocation | 3 | 2013 | 281 | 0.120 |
Why?
| Lung Injury | 1 | 2014 | 25 | 0.120 |
Why?
| Phenols | 1 | 2015 | 113 | 0.110 |
Why?
| Heart Diseases | 1 | 2016 | 206 | 0.110 |
Why?
| Butyric Acid | 1 | 2013 | 10 | 0.110 |
Why?
| Rats, Long-Evans | 3 | 2008 | 26 | 0.110 |
Why?
| Prodrugs | 1 | 2013 | 32 | 0.110 |
Why?
| Radiation Protection | 2 | 2016 | 47 | 0.110 |
Why?
| Organ Specificity | 2 | 2010 | 108 | 0.110 |
Why?
| United States | 2 | 2020 | 4860 | 0.110 |
Why?
| Choline Deficiency | 1 | 2012 | 23 | 0.110 |
Why?
| Choline | 1 | 2012 | 61 | 0.100 |
Why?
| Mice, Inbred BALB C | 2 | 2015 | 304 | 0.100 |
Why?
| Folic Acid Deficiency | 1 | 2012 | 43 | 0.100 |
Why?
| Acrylamide | 1 | 2012 | 5 | 0.100 |
Why?
| Genes, ras | 1 | 2012 | 43 | 0.100 |
Why?
| Polymerase Chain Reaction | 2 | 2010 | 453 | 0.100 |
Why?
| Triglycerides | 1 | 2013 | 159 | 0.100 |
Why?
| Epithelial Cells | 4 | 2015 | 209 | 0.100 |
Why?
| S-Adenosylhomocysteine | 1 | 2011 | 47 | 0.100 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 388 | 0.100 |
Why?
| Epoxy Compounds | 1 | 2012 | 45 | 0.100 |
Why?
| Cell Differentiation | 1 | 2015 | 651 | 0.100 |
Why?
| S-Adenosylmethionine | 1 | 2011 | 63 | 0.100 |
Why?
| Models, Animal | 2 | 2016 | 233 | 0.100 |
Why?
| Estrogens | 2 | 2010 | 227 | 0.100 |
Why?
| Immunohistochemistry | 3 | 2010 | 973 | 0.100 |
Why?
| Biological Transport | 1 | 2012 | 174 | 0.100 |
Why?
| Environment | 1 | 2012 | 84 | 0.100 |
Why?
| Folic Acid | 1 | 2012 | 135 | 0.100 |
Why?
| Testis | 2 | 2008 | 69 | 0.100 |
Why?
| Lipid Metabolism | 1 | 2012 | 175 | 0.100 |
Why?
| Guanine | 1 | 2011 | 40 | 0.100 |
Why?
| Mice, Inbred NOD | 1 | 2011 | 96 | 0.100 |
Why?
| Up-Regulation | 2 | 2013 | 452 | 0.100 |
Why?
| Fatty Liver | 1 | 2012 | 127 | 0.100 |
Why?
| Inhalation | 1 | 2010 | 6 | 0.100 |
Why?
| Histone Demethylases | 1 | 2010 | 16 | 0.090 |
Why?
| Liver Neoplasms | 2 | 2012 | 326 | 0.090 |
Why?
| Mammary Neoplasms, Animal | 1 | 2010 | 35 | 0.090 |
Why?
| Oncogenes | 1 | 2010 | 57 | 0.090 |
Why?
| Genes, Tumor Suppressor | 1 | 2010 | 73 | 0.090 |
Why?
| Repressor Proteins | 1 | 2010 | 151 | 0.090 |
Why?
| Antigens, Nuclear | 1 | 2009 | 24 | 0.080 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 475 | 0.080 |
Why?
| Neoplastic Stem Cells | 1 | 2010 | 103 | 0.080 |
Why?
| Muscles | 1 | 2009 | 103 | 0.080 |
Why?
| Lymphopoiesis | 1 | 2008 | 2 | 0.080 |
Why?
| Methyl-CpG-Binding Protein 2 | 1 | 2008 | 13 | 0.080 |
Why?
| Castration | 1 | 2008 | 14 | 0.080 |
Why?
| Ribonuclease III | 1 | 2008 | 12 | 0.080 |
Why?
| Endoribonucleases | 1 | 2008 | 15 | 0.080 |
Why?
| Abnormalities, Radiation-Induced | 1 | 2008 | 7 | 0.080 |
Why?
| Microarray Analysis | 1 | 2008 | 73 | 0.080 |
Why?
| Lung Neoplasms | 1 | 2014 | 606 | 0.080 |
Why?
| DEAD-box RNA Helicases | 1 | 2008 | 34 | 0.080 |
Why?
| Ovariectomy | 1 | 2008 | 119 | 0.080 |
Why?
| Germ-Line Mutation | 1 | 2008 | 61 | 0.080 |
Why?
| Alpha Particles | 1 | 2007 | 1 | 0.070 |
Why?
| Radiation Tolerance | 1 | 2008 | 85 | 0.070 |
Why?
| Air Pollutants | 1 | 2008 | 60 | 0.070 |
Why?
| Parents | 1 | 2009 | 314 | 0.070 |
Why?
| Cytosine | 1 | 2006 | 30 | 0.070 |
Why?
| Skin | 1 | 2009 | 409 | 0.070 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2006 | 122 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 142 | 0.060 |
Why?
| Lymphoma | 1 | 2005 | 66 | 0.060 |
Why?
| Antioxidants | 2 | 2017 | 249 | 0.060 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 166 | 0.060 |
Why?
| Faculty | 1 | 2024 | 72 | 0.060 |
Why?
| Research Personnel | 1 | 2024 | 66 | 0.060 |
Why?
| Cellular Microenvironment | 1 | 2024 | 26 | 0.060 |
Why?
| DNA Breaks, Double-Stranded | 2 | 2016 | 72 | 0.060 |
Why?
| Universities | 1 | 2024 | 161 | 0.060 |
Why?
| Neoplasm Proteins | 1 | 2005 | 322 | 0.060 |
Why?
| Program Evaluation | 1 | 2024 | 354 | 0.050 |
Why?
| Rabbits | 1 | 2023 | 370 | 0.050 |
Why?
| Pilot Projects | 1 | 2024 | 699 | 0.050 |
Why?
| Sex Factors | 3 | 2008 | 691 | 0.050 |
Why?
| Disease Progression | 2 | 2015 | 825 | 0.050 |
Why?
| Monocytes | 1 | 2021 | 131 | 0.050 |
Why?
| Adult | 2 | 2024 | 13236 | 0.040 |
Why?
| Carbohydrate Metabolism | 1 | 2017 | 26 | 0.040 |
Why?
| Enzymes | 1 | 2017 | 28 | 0.040 |
Why?
| Phosphorylation | 2 | 2011 | 535 | 0.040 |
Why?
| Chromosome Painting | 1 | 2017 | 6 | 0.040 |
Why?
| DNA Probes | 1 | 2017 | 30 | 0.040 |
Why?
| Metaphase | 1 | 2016 | 44 | 0.040 |
Why?
| Body Burden | 1 | 2016 | 11 | 0.040 |
Why?
| Fluorescent Dyes | 1 | 2017 | 102 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2017 | 192 | 0.030 |
Why?
| DNA Repair Enzymes | 1 | 2016 | 44 | 0.030 |
Why?
| Solar Activity | 1 | 2015 | 7 | 0.030 |
Why?
| Collagen | 1 | 2017 | 206 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 90 | 0.030 |
Why?
| Printing | 1 | 2015 | 4 | 0.030 |
Why?
| Endpoint Determination | 1 | 2015 | 24 | 0.030 |
Why?
| Welding | 1 | 2015 | 3 | 0.030 |
Why?
| Steel | 1 | 2015 | 5 | 0.030 |
Why?
| Ethinyl Estradiol | 1 | 2015 | 8 | 0.030 |
Why?
| Inhalation Exposure | 1 | 2015 | 32 | 0.030 |
Why?
| Complement C3 | 1 | 2015 | 24 | 0.030 |
Why?
| Translocation, Genetic | 1 | 2017 | 264 | 0.030 |
Why?
| Environmental Monitoring | 1 | 2015 | 65 | 0.030 |
Why?
| Titanium | 1 | 2015 | 48 | 0.030 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2015 | 47 | 0.030 |
Why?
| DNA End-Joining Repair | 1 | 2014 | 13 | 0.030 |
Why?
| Receptors, Progesterone | 1 | 2015 | 63 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 138 | 0.030 |
Why?
| Homologous Recombination | 1 | 2014 | 40 | 0.030 |
Why?
| Infant | 1 | 2023 | 3567 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2015 | 130 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2015 | 201 | 0.030 |
Why?
| Stem Cells | 1 | 2015 | 171 | 0.030 |
Why?
| DNA-Directed DNA Polymerase | 1 | 2014 | 92 | 0.030 |
Why?
| Cell Survival | 1 | 2015 | 600 | 0.030 |
Why?
| Protein Binding | 1 | 2015 | 660 | 0.030 |
Why?
| Genomics | 1 | 2015 | 286 | 0.030 |
Why?
| Flow Cytometry | 1 | 2015 | 476 | 0.030 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2015 | 186 | 0.030 |
Why?
| Signal Transduction | 2 | 2013 | 1618 | 0.030 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2013 | 53 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2012 | 23 | 0.030 |
Why?
| Rats, Wistar | 1 | 2013 | 223 | 0.030 |
Why?
| Histone Deacetylases | 1 | 2013 | 50 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2015 | 688 | 0.030 |
Why?
| Animal Feed | 1 | 2012 | 58 | 0.030 |
Why?
| Adenoma, Liver Cell | 1 | 2012 | 9 | 0.030 |
Why?
| Carcinogenicity Tests | 1 | 2012 | 29 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 83 | 0.030 |
Why?
| Child | 2 | 2016 | 6847 | 0.020 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2011 | 28 | 0.020 |
Why?
| Cation Transport Proteins | 1 | 2011 | 27 | 0.020 |
Why?
| Genetic Variation | 1 | 2012 | 213 | 0.020 |
Why?
| Animals, Newborn | 1 | 2012 | 367 | 0.020 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 12 | 0.020 |
Why?
| Aged | 1 | 2024 | 9310 | 0.020 |
Why?
| Genes, p53 | 1 | 2010 | 51 | 0.020 |
Why?
| Homeostasis | 1 | 2011 | 200 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2009 | 52 | 0.020 |
Why?
| Middle Aged | 1 | 2024 | 12069 | 0.020 |
Why?
| Spermatocytes | 1 | 2008 | 3 | 0.020 |
Why?
| Industry | 1 | 2008 | 17 | 0.020 |
Why?
| Spermatozoa | 1 | 2008 | 23 | 0.020 |
Why?
| Age Factors | 1 | 2011 | 1087 | 0.020 |
Why?
| Air Pollution | 1 | 2008 | 42 | 0.020 |
Why?
| Pregnancy | 1 | 2015 | 2607 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2008 | 175 | 0.020 |
Why?
| Tissue Culture Techniques | 1 | 2007 | 40 | 0.020 |
Why?
| Bronchi | 1 | 2007 | 43 | 0.020 |
Why?
| Rad51 Recombinase | 1 | 2006 | 22 | 0.020 |
Why?
| Trachea | 1 | 2007 | 52 | 0.020 |
Why?
| Keratinocytes | 1 | 2007 | 90 | 0.020 |
Why?
| Serine Proteases | 1 | 2005 | 2 | 0.020 |
Why?
| Retinoblastoma Protein | 1 | 2005 | 19 | 0.020 |
Why?
| Bone Marrow | 1 | 2008 | 362 | 0.020 |
Why?
|
|
Koturbash's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|